There’s no possible way I could be pregnant!

January 8, 2026

by Maureen K. Baldwin, MD MPH

Any test obtained in a clinic, research, or even in a home setting has the potential to have false positive results. Setting aside user errors, such as waiting too long to read a home pregnancy test, or mis-labeling patient samples, there are uncommon but not rare instances of false positive pregnancy test results. The reasons for these false results are slightly different between urine and serum HCG tests because even though the tests are set up to detect the same molecule, the assays are different (Table 1). Also, the circumstances under which we might be obtaining urine versus serum HCG are different. Urine samples are more likely obtained for screening purposes, and serum for diagnostic testing or trend analysis. Using a diagnostic test for a screening purpose can result in higher rates of false positive results [1].

Table 1. False positive pregnancy test sources

Not possibly pregnant Serum HCG NEG Serum HCG low POS
Urine HCG NEG Heterophile antibodies
Urine HCG POS Contamination Pituitary HCG with low clearance
LH cross-reaction in menopause

Dear consultant, a patient has a positive urine pregnancy test and says they can’t possibly be pregnant. What do I do next?

It’s reasonable to start this evaluation with an assessment of how likely it is that the patient might be pregnant. If there is any possibility, then they are likely pregnant until proven otherwise since urine pregnancy tests are very accurate [2] . However, if the patient does not have uterus/ovaries/fallopian tubes, is menopausal, or their only sexual partner has had a vasectomy, then further steps should be taken to assess the source of the positive test. Keep in mind that you don’t want to miss rare occurrences of ectopic pregnancy, gestational trophoblastic disease, and vasectomy failure.

The first step is to repeat the urine test using a new sample on a different machine. A second step would be to confirm with a serum HCG. A negative serum HCG confirms a false urine test. A falsely positive urine test can be due to exogeneous HCG or blood contamination and repeating the test will usually resolve the question. If the serum HCG is still unexpectedly positive, then move on to the section below on unexpected positive serum HCG. Repeating the urine pregnancy test and confirming with serum HCG will resolve most unexpected positive urine pregnancy tests.

Dear consultant, a patient has a positive serum pregnancy test and says they can’t possibly be pregnant. What do I do next?

There are more potential reasons for false positive serum HCG tests than for false positive urine HCG tests, particularly when used for screening in patients at low or no risk for pregnancy. Good general advice is to start with urine testing first (and then stop checking!). However, if an unexpected positive urine test has led to testing serum HCG, or there is an unexpected serum HCG result, always start by screening for pregnancy potential and repeating the test.

The most common reason for an unexpected serum HCG is an incompletely resolved pregnancy (e.g., retained gestational tissue or the normal course of renal clearance of the large HCG molecule after the end of a pregnancy) and less commonly, gestational trophoblastic disease or a germ cell tumor. Circulating HCG is detectable for up to 6 weeks after the end of a pregnancy [3] . We commonly recommend repeating HCG in 4 weeks after medication abortion, for example, but 20% still have detectable serum HCG at that time (and that is likely normal for them if they are asymptomatic – just repeat in 1-2 weeks) [4] . Assessment of the potential for new pregnancy and interval repeat HCG are the typical next steps. If levels are plateaued, consider uterine aspiration to manage retained gestational tissue. If increasing, consider a new pregnancy. Decreasing HCG can be followed weekly until it reaches a non-pregnant level.

If a urine HCG has not yet been obtained, this can help the evaluation. A mismatch of false-positive serum HCG but negative urine HCG might occur when the individual has interfering antibodies that bind to the radio-immune assay. This so-called “phantom” or “heterophile” antibodies result in low level serum HCG detection [5] . If needed, this situation is confirmed by asking the laboratory to perform serial dilutions. Due to antibody binding, the results will not decrease proportionally compared to the dilutions. A negative urine HCG in the presence of low-level positive serum HCG confirms heterophile antibodies and further dilution testing is not necessary.

Other times, both low-level serum HCG (in the tens to low hundreds) and positive urine HCG may result when there are higher levels of circulating pituitary hormones that can bind to the assay due to similar molecular structure [6] . These include luteinizing hormone (LH), which is elevated in menopause, and elevated thyroid stimulating hormone (TSH). Additionally, since HCG is produced at low levels in multiple tissues, a false positive HCG can occur in patients with low renal clearance [7] . An unexpected positive urine and low serum HCG in the setting of menopause or chronic kidney disease should not require further evaluation. Since these HCG levels are often so low that they do not result in a positive urine pregnancy test, starting with history-based screening or urine screening is a good practice prior to common procedures that require pregnancy screening, such as dialysis.

Levels of serum HCG will be much higher in the setting of germ cell tumors and gestational trophoblastic disease. Higher unexpected serum HCG (in the thousands) requires imaging and sometimes further laboratory analyses to evaluate the source.

Dear consultant, a patient has a positive urine and serum pregnancy test that are low and not resolving, and they might be pregnant. How much testing do I need to do for confirmation?!

Some cases may require additional testing over multiple visits. However, consider the initial indication for the unexpected test and the potential risk of pregnancy versus false positive result. Take for example, the following case: A 48-year-old presents to clinic for IUD exchange for contraception. The patient has been amenorrheic for several years. Urine pregnancy test was obtained per clinic protocol and was found to be positive. It was repeated on two different machines. Last intercourse was over one month prior. Serum HCG was obtained which was trended at 121, 106, and then 91 IU/L. Ultrasound was non-diagnostic, and the differential diagnosis included presumed early pregnancy loss versus ectopic pregnancy. Uterine aspiration was performed which was atrophic. Following uterine aspiration, HCG declined only slightly to 81 IU/L. Upon further investigation of the patient’s history, she was noted to have chronic kidney disease with Cr 1.53 mg/dL. A serum FSH was obtained which was 99 IU/L. At this point, the workup could be considered complete since the patient is most certainly menopausal and this story is classic for cross-reaction of the HCG test due to elevated LH in combination with low renal clearance of endogenous pituitary HCG. Further proof of this diagnosis could be obtained by suppressing LH. In this case, administration of combined estrogen/progestin resulted in decreased HCG to 19 and then 5 IU/L. Repeat FSH at that time was 38 IU/L, confirming menopause [8] . HCG later increased to 45 IU/L upon discontinuation of the combined oral contraceptive. This case highlights the potential for false positive urine and serum HCG in patients undergoing routine screening for pregnancy who may already be menopausal and have other factors that predispose them to false positive HCG.

Dear consultant, why don’t we have to do a pregnancy test before starting contraception?

The U.S. Centers for Disease Control propose a history-based screening prior to starting contraception in their Selected Practice Recommendations that does not include HCG screening and has 99-100% negative predictive value to rule out pregnancy (Box 1) [9]. Screening for current pregnancy starts with taking a history that includes timing of intercourse related to menstrual timing, contraceptive use, and recent pregnancy history. To avoid false positive results, all situations requiring pregnancy screening should consider using this history-based format and starting with urine HCG if indicated.

Box 1. How to be reasonably certain that a patient is not pregnant

A health care provider can be reasonably certain that a person is not pregnant if there are no symptoms or signs of pregnancy and they meet any one of the following criteria:

  • Is ≤7 days after the start of normal menses
  • Has not had sexual intercourse since the start of last normal menses
  • Has been correctly and consistently using a reliable method of contraception
  • Is ≤7 days after spontaneous or induced abortion
  • Is within 4 weeks postpartum
  • Is fully or nearly fully breastfeeding/chestfeeding (exclusively or the vast majority [>85%] of feeds), amenorrheic, and <6 months postpartum

Abbreviations: U.S. MEC = U.S. Medical Eligibility Criteria for Contraceptive Use; U.S. SPR = U.S. Selected Practice Recommendations for Contraceptive Use.

Modified from the U.S. CDC Selected Practice Recommendations 2016 [9].

References

  1. Bogduk, N., On understanding reliability for diagnostic tests. Interv Pain Med,
    2022. 1: p. 100124.
  2. Cole, L.A., The hCG assay or pregnancy test. Clin Chem Lab Med, 2012. 50: p.
    617-30.
  3. Cortes-Charry, R., Corredor, N., Fernandez, J., Salazar, A., Rodriguez, L., and
    Fargione, M., Determining the time required to achieve negative human chorionic
    gonadotropin value after a nonmolar pregnancy: preliminary results. J Reprod
    Med, 2014. 59: p. 209-12.
  4. Raymond, E.G., Anger, H.A., Chong, E., Haskell, S., Grant, M., Boraas, C., et al.,
    &quot;False positive&quot; urine pregnancy test results after successful medication abortion.
    Contraception, 2021. 103: p. 400-403.
  5. Bolstad, N., Warren, D.J., and Nustad, K., Heterophilic antibody interference in
    immunometric assays. Best Pract Res Clin Endocrinol Metab, 2013. 27: p. 647-
    61.
  6. Demir, A.Y., Musson, R.E., Schols, W.A., and Duk, J.M., Pregnancy, malignancy
    or mother nature? Persistence of high hCG levels in a perimenopausal woman.
    BMJ Case Rep, 2019. 12.
  7. Ostreni, I., Colatosti, A., Basile, E.J., and Rafa, O., Elevated Beta-Human
    Chorionic Gonadotropin in a Non-pregnant Female With Altered Kidney Function.
    Cureus, 2022. 14: p. e23747.
  8. Baldwin, M.K. and Jensen, J.T., Contraception during the perimenopause.
    Maturitas, 2013. 76: p. 235-42.
  9. Curtis, K.M., Nguyen, A.T., Tepper, N.K., Zapata, L.B., Snyder, E.M., Hatfield-
    Timajchy, K., et al., U.S. Selected Practice Recommendations for Contraceptive
    Use, 2024. MMWR Recomm Rep, 2024. 73: p. 1-77.

Other Latebreakers

Jan. 08, 2026

There’s no possible way I could be pregnant!

Nov. 01, 2025

Answering your questions about wellness exams for adults assigned female at birth – often called the “well woman exam”

Sep. 05, 2025

Acute Heavy Menstrual Bleeding!

Aug. 01, 2025

New and Updated Guidelines for Cervical Cancer Screening

Jun. 20, 2025

The Patient Asks—I’m on Depo-Provera, What’s My Risk for Meningioma?

May. 01, 2025

Clinical Tools for Contraceptive Eligibility and Practice

Jan. 13, 2025

New ovarian cyst despite CHC use by patient with PCOs?

Nov. 14, 2024

Mood Swings, Depression, and CHCs

Oct. 15, 2024

Higher Body Weight Effect on Combined Hormonal Contraceptives

Sep. 09, 2024

Perimenopause: pregnancy risks

Aug. 13, 2024

NEW! 2024 MEC & SPR (Free from the CDC)

Jul. 19, 2024

Medication Interactions and Contraceptive Effectiveness

Jun. 05, 2024

“Birth control has a TikTok problem.”

May. 08, 2024

Implant: Unpredictable Bleeding and Management

Mar. 19, 2024

Weight Changes and hormonal contraceptives

Feb. 16, 2024

What most affects contraceptive continuation?

Jan. 03, 2024

Resuming CT monthly updates! Introducing the new edition of Contraceptive Technology

Dec. 20, 2021

Substance use disorder: contraceptive options counseling

Oct. 15, 2021

What’s New in Contraception?

Sep. 21, 2021

Contraceptive Technology Conference!

Aug. 25, 2021

Biologic sexism of STIs

Jul. 16, 2021

Excess breast cancer deaths after COVID-19

Jul. 04, 2021

Contraception for patients with medical conditions

May. 18, 2021

Pelvic Floor Dysfunction

Mar. 04, 2021

Treating vulvodynia

Feb. 11, 2021

Puzzling Over the Hurt Down-Under

Jan. 06, 2021

Serious Mental Illness and Contraception

Oct. 28, 2020

New 13-Cycle Vaginal Contraceptive System

Oct. 08, 2020

The Future of Family Planning in Post-COVID America

Sep. 09, 2020

New ASCCP Guidelines: Implications for FP

Aug. 02, 2020

On the alert: mood disorders during 2020 stressors

Jun. 25, 2020

Sex in the Time of COVID-19

May. 08, 2020

Challenges old and new during the pandemic

Mar. 31, 2020

Reproductive health in the time of Covid-19

Mar. 09, 2020

Talking about toys

Feb. 10, 2020

Missed Pills: The Problem That Hasn’t Gone Away

Jan. 02, 2020

Find the “yes! . . . and” rather than “no” or “but”

Nov. 01, 2019

Digital Family Planning: the Future is Now

Oct. 08, 2019

Irregular Bleeding Due to Contraceptives

Sep. 06, 2019

When she’s low on libido…

Aug. 06, 2019

Ouch! Best approaches to menstrual pain

Jun. 27, 2019

Contraceptive efficacy: understanding how user and method characteristics play their part

May. 29, 2019

Strategizing treatment for chronic heavy menstrual bleeding

May. 10, 2019

Perimenopause

Mar. 27, 2019

Untangling the literature on obesity and contraception

Feb. 26, 2019

High tech apps for no-tech FABM

Jan. 25, 2019

Menstrual exacerbation of other medical conditions

Jan. 04, 2019

From Princeton University: Thomas James Trussell (1949-2018)

Nov. 30, 2018

The Short and Long of IUD Use Duration

Oct. 30, 2018

Selecting a Method When Guidance Isn’t Clear-cut

Oct. 04, 2018

Healthcare in the Time of Digital Expansion

Aug. 30, 2018

Combined pills’ effect on mood disorders

Aug. 30, 2018

The Scoop on Two New FDA-Approved Contraceptive Methods

Aug. 01, 2018

Pregnancy of unknown location—meeting the challenge

Jul. 03, 2018

Big “yes” (with caveats) to CHCs during perimenopause

Apr. 02, 2018

Abortion in the U.S.: safe, declining, and under threat

Feb. 02, 2018

Hope for ovarian cancer screening test

Jan. 03, 2018

Breast cancer still a small risk with some hormonal contraceptives

Dec. 04, 2017

New treatment modality for BV

Nov. 07, 2017

Record rate of HPV-related throat cancer

Oct. 03, 2017

Viruses in semen potentially transmissible

Sep. 01, 2017

Don’t Abstain from Your Role in Abstinence

Jul. 26, 2017

Teens births declining but geographic ‘hotspots’ defy trend

Jun. 27, 2017

Online Medical Abortion Service Effective and Safe

May. 30, 2017

Do Women Really Need to Wait That Long?

May. 05, 2017

Reassuring news on depression and OC use

Apr. 06, 2017

PMDD: Genetic clues may lead to improved treatment

Mar. 02, 2017

Breast cancer risk when there is a family history

Feb. 03, 2017

Body weight link to breast and endometrial cancers (and 11 others)

Jan. 03, 2017

Family Planning in 2017 and Beyond

Dec. 01, 2016

Make Me Cry: Depression Link (Again)?

Nov. 02, 2016

Managing implant users’ bleeding and spotting

Oct. 13, 2016

Zika: Updated guidance for providers

Sep. 06, 2016

Pharmacist-prescribed contraceptives

Aug. 01, 2016

Hot off the press! 2016 MEC and SPR

Jul. 05, 2016

Zika virus fears prompt increased request for abortion in nations outlawing abortions

Jun. 13, 2016

Opioid use epidemic among reproductive-age women

May. 04, 2016

Good news on the family planning home front!

Apr. 04, 2016

War Against Planned Parenthood Hurts Women

Feb. 16, 2016

Win-win for both treatment and prevention

Feb. 08, 2016

Center of the Storm

Dec. 01, 2015

Ambivalence

Nov. 02, 2015

Menopause, mood, mental acuity, and hormone therapy

Oct. 01, 2015

Emergency contraception for teens

Sep. 03, 2015

Postpartum Contraception: Now, Not Later

Aug. 03, 2015

Reproductive tract infections, sexually transmitted infections, or sexually transmitted diseases: “a rose by any other name…”

Jun. 25, 2015

Are we practicing what we preach?

Jun. 02, 2015

Be alert to VTE in hormonal contraceptive users

May. 04, 2015

LARC among teens increased 15-fold, but not enough

Mar. 30, 2015

Brain cancer and hormonal contraception

Mar. 02, 2015

Free tools: Easy access to the US Medical Eligibility Criteria for Contraceptive Use

Feb. 02, 2015

Alcohol consumption when pregnancy is unwanted or unintended

Jan. 12, 2015

Latest Data on Contraceptive Use in the United States

Dec. 01, 2014

LateBreaker sampler from Contraceptive Technology conference

Nov. 05, 2014

Emergency Contraceptive Pill Efficacy and BMI/Body Weight

Sep. 29, 2014

Handout on Unintended Pregnancy and Contraceptive Choice

Aug. 27, 2014

Ask About Withdrawal (Really!)

Jul. 31, 2014

Rules to Practice By: Safety First and Cleanliness is Close to. . .

Jul. 01, 2014

What’s Vanity Fair Got Against the NuvaRing?

Jun. 02, 2014

Promising New Treatment for Hepatitis C

May. 01, 2014

Numbers matter, so make them simple for patients

Apr. 01, 2014

The Recession’s Effect on Unintended Pregnancies

Mar. 05, 2014

Lessons Learned from the Contraceptive CHOICE Project: The Hull LARC Initiative

Feb. 03, 2014

Applying the “New” Cervical Cytology Guidelines in Your Practice

Jan. 02, 2014

Acute Excessive Uterine Bleeding: New Management Strategies

Dec. 03, 2013

Medical indications for IUD use in teens

Oct. 09, 2013

Whatever happened to PID?

Oct. 05, 2013

Update on Emergency Contraception

Oct. 01, 2013

Contraceptivetechnology.com New and Improved